Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00743210 · ClinicalTrials.gov registry record · Phase 1
Oral L-Citrulline and ADMA in Pregnancy
A Phase 1 study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- Phase 1
- Development phase
- 41
- Enrollment target
NCT00743210 is a Phase 1 study that has completed, run by University of Pittsburgh. The registered enrollment target is 41 participants.
The verdict
NCT00743210, a Phase 1 study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 41 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if oral of L-citrulline (3 grams/day) for 3 weeks provided in mid-pregnancy to obese subjects will decrease the plasma ADMA/L-arginine ratio, lower maternal blood pressure, improve endothelial-dependent vascular function and peripheral vascular stiffness, and improve uterine artery Doppler resistance and flow.
Interventions
- DRUG Placebo
- DRUG L-citrulline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2010-01 |
| Est. Completion | 2013-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00743210
The ClinicalTrials.gov registry entry for NCT00743210 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00743210 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00743210 about?
NCT00743210 is a clinical study titled "Oral L-Citrulline and ADMA in Pregnancy". The purpose of this study is to determine if oral of L-citrulline (3 grams/day) for 3 weeks provided in mid-pregnancy to obese subjects will decrease the plasma ADMA/L-arginine ratio, lower maternal blood pressure, improve endothelial-dependent vascular function and peripheral vascular stiffness, an...
What is the current status of trial NCT00743210?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 41 participants. The study started on 2010-01. Estimated completion is 2013-06.
What interventions are being tested in trial NCT00743210?
The interventions under investigation include: Placebo (DRUG), L-citrulline (DRUG).
Who is sponsoring clinical trial NCT00743210?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.